A female urinary barrier system product that includes an exterior vaginal attachment pad for providing a female-user with means to prevent the spread of infectious diseases into their vaginal opening and urinary tract. The product provides a female-user a hand depressible attachment pad useful for enclosing/covering the vagina prior to a bowel movement or just prior to wiping. The product embodies a barrier that protects a female-user's urethra from fecal matter and other external harmful pathogenic bacteria, viruses, and fungi entering therein. Another version of the present invention is an attachable pad applicable to an undergarment of a female-user for purposes of prevention of bacterial inoculation from exterior sources.

A female urinary barrier system product that includes an exterior vaginal attachment pad for providing a female-user with means to prevent the spread of infectious diseases into their vaginal opening and urinary tract. The product provides a female-user a hand depressible attachment pad useful for enclosing/covering the vagina prior to a bowel movement or just prior to wiping. The product embodies a barrier that protects a female-user's urethra from fecal matter and other external harmful pathogenic bacteria, viruses, and fungi entering therein. Another version of the present invention is an attachable pad applicable to an undergarment of a female-user for purposes of prevention of bacterial inoculation from exterior sources.

Contraceptive methods, systems, and devices generally improve the ease, speed, and reliability with which a contraceptive device can be deployed transcervically into an ostium of a fallopian tube. The contraceptive device may remain in a small profile configuration while a sheath is withdrawn proximally, and is thereafter expanded to a large profile configuration engaging the surrounding tissues, by manipulating one or more actuators of a proximal handle with a single hand. This leaves the other hand free to manipulate a hysteroscope, minimizing the number of health care professional required to deploy the contraceptive device.

An intravaginal device having an aperture and a withdrawal assembly. The withdrawal assembly has a withdrawal member and an obstruction.

An intravaginal device having an aperture and a withdrawal assembly. The withdrawal assembly has a withdrawal member and an obstruction.

A fornix manipulator includes a collar and stabilizer. The collar has a first end and a second end, the second end having an opening and diameter greater than the first end and the first end having an opening to receive a cervix into the collar. The stabilizer has a base portion defining a guide hole and a plurality of prongs extending from the base portion to contact the first end of the collar.

A fornix manipulator includes a collar and stabilizer. The collar has a first end and a second end, the second end having an opening and diameter greater than the first end and the first end having an opening to receive a cervix into the collar. The stabilizer has a base portion defining a guide hole and a plurality of prongs extending from the base portion to contact the first end of the collar.

A system for treating a fallopian tube to promote contraception includes a catheter device, a tissue disrupting head coupled with the catheter device, and a fluid delivery port for delivering a sclerosant to the mucosal lining of the fallopian tube before, during or after disruption of the mucosal lining by the tissue disrupting head. The catheter device may include a handle and a catheter shaft having a proximal end coupled with the handle and a distal end sized and configured to be advanced through a cervix and into the fallopian tube. The tissue disrupting head may include at least one tissue disrupting member configured to operable to mechanically disrupt a mucosal lining of the fallopian tube by contacting the tissue disrupting member with the mucosal lining and moving the tissue disrupting head. The fluid delivery port may be located in the catheter shaft or the tissue disrupting head.

A system for treating a fallopian tube to promote contraception includes a catheter device, a tissue disrupting head coupled with the catheter device, and a fluid delivery port for delivering a sclerosant to the mucosal lining of the fallopian tube before, during or after disruption of the mucosal lining by the tissue disrupting head. The catheter device may include a handle and a catheter shaft having a proximal end coupled with the handle and a distal end sized and configured to be advanced through a cervix and into the fallopian tube. The tissue disrupting head may include at least one tissue disrupting member configured to operable to mechanically disrupt a mucosal lining of the fallopian tube by contacting the tissue disrupting member with the mucosal lining and moving the tissue disrupting head. The fluid delivery port may be located in the catheter shaft or the tissue disrupting head.

Systems and methods of using and imaging shear-thinning biomaterial compositions are provided. More particularly, systems and methods of providing reversible birth control and/or for delivering therapeutics to reproductive organs are provided. A method includes administering a biomaterial into fallopian tubes, uterus, or vas deferens of the subject, where the biomaterial is a shear-thinning nanocomposite.